| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 04/16/2014 | CN103044537B CFTR recombinant protein, its encoding gene and use |
| 04/16/2014 | CN102936598B Coding gene of anti-Cry1Ac toxin single-chain variable fragments (scFv) and immuno-polymerase chain reaction (PCR) detection method |
| 04/16/2014 | CN102746414B Sedimentation method of lipopolysaccharides |
| 04/16/2014 | CN102660551B VHH (variable domain of heavy chain of heavy-chain antibody) antibody gene derived from anti-CyPA (CyclophilinA) animal of family Camelidae, encoded polypeptide, and application thereof |
| 04/16/2014 | CN102618557B Recombinant avian flavivirus E protein and application thereof |
| 04/16/2014 | CN102532284B A mutated immunoglobulin-binding protein |
| 04/16/2014 | CN102459586B Expression vector for establishing hyper-producing cells, and hyper-producing cells |
| 04/16/2014 | CN102321923B Preparation method for monoclonal antibody library of tumor mucoprotein glycopeptide epitope |
| 04/16/2014 | CN102216330B Pharmaceutical compositions of antibodies for diseases caused by viruses |
| 04/16/2014 | CN102164961B Cross-species-specific PSCAxCD3, CD19xCD3, C-NETxCD3, endosialinxCD3, EpCAMxCD3, IGF-1RxCD3 or FAOalpha xCD3 bispecific single chain antibody |
| 04/16/2014 | CN102089324B Compositions and methods for the therapy and diagnosis of influenza |
| 04/16/2014 | CN101970496B Antibody against the csf-1 r |
| 04/16/2014 | CN101952426B Anti-BST2 antibody |
| 04/16/2014 | CN101687039B Engineered anti-alpha v- integrin hybrid antibodies |
| 04/15/2014 | US8697848 Method for reducing immunogenicity of therapeutic protein compositions |
| 04/15/2014 | US8697846 Methods of making monoclonal antibodies using fusion-peptide epitope adoptive transfer (F-PEAT) technology |
| 04/15/2014 | US8697845 Antibodies specifically directed to a soluble form of CTLA-4 |
| 04/15/2014 | US8697650 HSA-related compositions and methods of use |
| 04/15/2014 | US8697407 Compositions and methods for inhibiting MMSET |
| 04/15/2014 | US8697396 Modulation of antibody effector function by hinge domain engineering |
| 04/15/2014 | US8697355 Methods and compositions for determining the purity of chemically synthesized nucleic acids |
| 04/15/2014 | US8697083 Hypoallergenic chimeric proteins belonging to the lipid transfer family of parietaria judaica for use in the treatment of allergies |
| 04/15/2014 | US8697078 Antibodies that inhibit metalloproteins |
| 04/15/2014 | US8697075 Cancer specific antibody and cell surface proteins |
| 04/15/2014 | US8697071 Identification and engineering of antibodies with variant Fc regions and methods of using same |
| 04/15/2014 | US8697069 Methods related to TIM 3, a Th1-specific cell surface molecule, for activating antigen presenting cells |
| 04/15/2014 | US8697067 Methods for increasing the effectiveness of antibodies and/or FCY receptor-binding active ingredients |
| 04/15/2014 | US8697065 Non-natural ribonuclease conjugates as cytotoxic agents |
| 04/15/2014 | US8697061 Tumor specific oligosaccharide epitopes and use thereof |
| 04/15/2014 | CA2566355C Influenza virus vaccine composition and methods of use |
| 04/15/2014 | CA2565215C Method and system to remove soluble tnfr1, tnfr2, and il2 in patients |
| 04/15/2014 | CA2490186C Method for the treatment of multiple sclerosis |
| 04/15/2014 | CA2436208C A novel virus (cryptovirus) within the rubulavirus genus and uses therefor |
| 04/15/2014 | CA2427643C Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (sclc) |
| 04/15/2014 | CA2399298C Use of il-18 inhibitors |
| 04/15/2014 | CA2328414C Methods for detecting and inhibiting angiogenesis |
| 04/10/2014 | WO2014055998A1 Human anti-vegfr-2/kdr antibodies |
| 04/10/2014 | WO2014055967A2 Compositions and methods for treating diseases of protein aggregation involving ic3b deposition |
| 04/10/2014 | WO2014055897A2 Human monoclonal anti-pd-l1 antibodies and methods of use |
| 04/10/2014 | WO2014055893A1 Use of an ion exchange membrane to remove impurities from cell-binding agent cytotoxic agent conjugates |
| 04/10/2014 | WO2014055867A1 Methods for accelerating immune regeneration |
| 04/10/2014 | WO2014055842A1 Process for preparing stable antibody maytansinoid conjugates |
| 04/10/2014 | WO2014055835A1 Alternative pathway specific antibodies for treating hemolytic diseases |
| 04/10/2014 | WO2014055800A1 A family of synthetic polynucleotide-binding peptides and uses thereof |
| 04/10/2014 | WO2014055663A1 Specific delivery of toxins conjugated wtih antibodies to activated matriptase |
| 04/10/2014 | WO2014055657A1 Use of a trans-signaling approach in chimeric antigen receptors |
| 04/10/2014 | WO2014055648A1 Combination of anti-kir antibodies and anti-pd-1 antibodies to treat cancer |
| 04/10/2014 | WO2014055544A1 Treating vascular disease and complications thereof |
| 04/10/2014 | WO2014055442A2 Compositions and methods for targeting stromal cells for the treatment of cancer |
| 04/10/2014 | WO2014055370A1 Compostions and methods for producing glycoproteins |
| 04/10/2014 | WO2014055097A1 Androgen suppression, prostate-specific membrane antigen and the concept of conditionally enhanced vulnerability |
| 04/10/2014 | WO2014054804A1 Heterodimeric protein composition |
| 04/10/2014 | WO2014054675A1 Method for detecting primary aldosteronism, and monoclonal antibody |
| 04/10/2014 | WO2014054046A1 Ordered reversible fibrils, aggregates and multimers of proteins and uses thereof |
| 04/10/2014 | WO2014053634A1 New neutralizing antibodies directed against hepatitis c virus |
| 04/10/2014 | WO2014053603A1 Morphine-6-glucuronide derivatives, immunogens and immunoassay |
| 04/10/2014 | WO2014053586A1 Her3 binding polypeptides |
| 04/10/2014 | WO2014053489A1 Compounds for treating the remyelination blockade in diseases associated with the expression of herv-w envelope protein |
| 04/10/2014 | WO2014036495A3 Diagnostic assays and kits for detection of folate receptor 1 |
| 04/10/2014 | WO2014018926A8 Methods and compositions for determining resistance to androgen receptor therapy |
| 04/10/2014 | WO2013188864A4 Anti-cd22 anti-idiotypic antibodies and uses thereof |
| 04/10/2014 | WO2013188448A3 Dual receptor antagonistic antigen-binding proteins and uses thereof |
| 04/10/2014 | WO2013054331A8 Antibodies to carcinoembryonic antigen-related cell adhesion molecule (ceacam) |
| 04/10/2014 | US20140100359 Dual Variable Domain Immunoglobulin and Uses Thereof |
| 04/10/2014 | US20140100358 Antibody production method |
| 04/10/2014 | US20140100130 Methods and Compositions for the Diagnosis of Ovarian Cancer |
| 04/10/2014 | US20140099716 Monoclonal antibody capable of binding integrin alpha 10 beta 1 |
| 04/10/2014 | US20140099708 Anti-IL12Rbeta1 Antibodies And Their Use In Treating Autoimmune And Inflammatory Disorders |
| 04/10/2014 | US20140099707 Antibody polypeptides that antagonize cd40l |
| 04/10/2014 | US20140099671 Il-1 binding proteins |
| 04/10/2014 | US20140099670 RANKL ANTIBODY-PTH/PTHrP CHIMERIC MOLECULES |
| 04/10/2014 | US20140099666 Compositions and methods for enhancing production of a biological product |
| 04/10/2014 | US20140099651 Immunoassays for meperidine and metabolites |
| 04/10/2014 | US20140099650 Monoclonal antibodies and detection methods for enzymes that confer resistance to phosphinothricin-n-acetyl-transferase |
| 04/10/2014 | US20140099340 Compositions and Methods for Targeting Stromal Cells for the Treatment of Cancer |
| 04/10/2014 | US20140099334 Anti-sema4d antibodies and epitopes |
| 04/10/2014 | US20140099332 Diagnostic assays and kits for detection of folate receptor 1 |
| 04/10/2014 | US20140099325 Human monoclonal antibodies to ctla-4 |
| 04/10/2014 | US20140099324 Herv-k antigens, antibodies, and methods |
| 04/10/2014 | US20140099321 Treating vascular disease and complications thereof |
| 04/10/2014 | US20140099320 Human binding molecules having killing activity against enterococci |
| 04/10/2014 | US20140099318 CD3-Binding Molecules Capable of Binding to Human and Non-Human CD3 |
| 04/10/2014 | US20140099317 Antibody polypeptides that antagonize cd40 |
| 04/10/2014 | US20140099315 Human Oncostatin M Antibodies and Methods of Use |
| 04/10/2014 | US20140099314 S. aureus polypeptide and antibodies |
| 04/10/2014 | US20140099313 Interleukin-13 binding proteins |
| 04/10/2014 | US20140099311 Anti-IL-6 Antibodies, Compositions, Methods and Uses |
| 04/10/2014 | US20140099310 Cancer targets and uses thereof |
| 04/10/2014 | US20140099309 Use of a Trans-Signaling Approach in Chimeric Antigen Receptors |
| 04/10/2014 | US20140099308 Novel EGFR-Binding Molecules and Immunoconjugates Thereof |
| 04/10/2014 | US20140099307 New Dendritic Cell Co-Stimulatory Molecules |
| 04/10/2014 | US20140099306 Ctla4 fusion proteins for the treatment of diabetes |
| 04/10/2014 | US20140099305 Compositions and methods for cancer immunotherapy |
| 04/10/2014 | US20140099304 Methods of Treating a Tauopathy |
| 04/10/2014 | US20140099303 Methods of Treating a Tauopathy |
| 04/10/2014 | US20140099299 Methods and Compositions for Cytomegalovirus IL-10 Protein |
| 04/10/2014 | US20140099280 Novel Superactive IL-33 Fragments, and Uses Thereof |
| 04/10/2014 | US20140099260 Anti-CD79B Antibodies and Immunoconjugates and Methods of Use |
| 04/10/2014 | US20140099259 Tumor-specific recognition molecules |
| 04/10/2014 | US20140099257 Androgen Suppression, Prostate-Specific Membrane Antigen and the Concept of Conditionally Enhanced Vulnerability |